Research Paper | Medical Science | India | Volume 7 Issue 10, October 2018
Intravitreal Triamcinolone Acetonide in Diabetic Macular Edema
Dr. Kabita Bora Baishya  | Dr. Suprio Kumar Datta
Abstract: Diabetic retinopathy (DR) is the most common microvascular complication of diabetes. The most common cause of vision loss in diabetic retinopathy is diabetic macular edema. Intravitreal injection of corticosteroids (triamcinolone acetonide), constitutes a newer, less destructive treatment modality in the management of diabetic macular edema. . Intravitreal triamcinolone acetonide is a favourable and promising therapeutic tool in managing diffuse diabetic macular oedema for certain duration of time with minimal transient side effect.
Keywords: Diabetic macular edema, OCT, intravitreal triamcinolone acetonide
Edition: Volume 7 Issue 10, October 2018,
Pages: 915 - 919
How to Cite this Article?
Dr. Kabita Bora Baishya, Dr. Suprio Kumar Datta, "Intravitreal Triamcinolone Acetonide in Diabetic Macular Edema", International Journal of Science and Research (IJSR), Volume 7 Issue 10, October 2018, pp. 915-919, https://www.ijsr.net/get_abstract.php?paper_id=ART20192017
How to Share this Article?
Similar Articles with Keyword 'OCT'
Role of Antisnake Venom (ASV) in Decreasing Severity of Acute Renal Failure in Snake Bite
Dr. Uddhav Khaire  | Dr. Syed Ammaruddin Chishty | Dr. Anupam Pal
In World First Transplant; A Man Received Genetically-Modified Pig Heart